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Overproduction of IL-6, a proinflammatory cytokine, is associated
with a spectrum of age-related conditions including cardiovascular
disease, osteoporosis, arthritis, type 2 diabetes, certain cancers,
periodontal disease, frailty, and functional decline. To describe the
pattern of change in IL-6 over 6 years among older adults under-
going a chronic stressor, this longitudinal community study as-
sessed the relationship between chronic stress and IL-6 production
in 119 men and women who were caregiving for a spouse with
dementia and 106 noncaregivers, with a mean age at study entry
of 70.58 (SD  8.03) for the full sample. On entry into this portion
of the longitudinal study, 28 of the caregivers’ spouses had already
died, and an additional 50 of the 119 spouses died during the 6
years of this study. Levels of IL-6 and health behaviors associated
with IL-6 were measured across 6 years. Caregivers’ average rate
of increase in IL-6 was about four times as large as that of
noncaregivers. Moreover, the mean annual changes in IL-6 among
former caregivers did not differ from that of current caregivers
even several years after the death of the impaired spouse. There
were no systematic group differences in chronic health problems,
medications, or health-relevant behaviors that might have ac-
counted for caregivers’ steeper IL-6 slope. These data provide
evidence of a key mechanism through which chronic stressors may
accelerate risk of a host of age-related diseases by prematurely
aging the immune response.
A growing body of evidence has implicated caregiving as arisk factor for health. Compared with noncaregivers, men
and women who provide care to a spouse with a stroke or
dementia report more infectious illness episodes (1), they have
poorer immune responses to influenza virus and pneumococcal
pneumonia vaccines (2–4), their wounds heal more slowly (5),
they are at greater risk for developing mild hypertension (6, 7),
and they may be at greater risk for coronary heart disease (8).
Moreover, a prospective longitudinal study found that the rel-
ative risk for all-cause mortality among strained caregivers was
63% higher than noncaregiving controls (9). In this study, we
provide evidence of one core pathway behind the diverse health
risks associated with caregiving and other chronic stressors: over-
production of IL-6, a key proinflammatory cytokine that appears to
enhance morbidity and mortality among older adults (10).
Recent medical literature has highlighted a spectrum of
age-associated diseases whose onset and course may be influ-
enced by proinflammatory cytokines, including cardiovascular
disease, osteoporosis, arthritis, type 2 diabetes, certain cancers,
Alzheimer’s disease, periodontal disease, and frailty and func-
tional decline. The link to cardiovascular disease, the leading
cause of death, has attracted the greatest attention; the associ-
ation with IL-6 is related in part to the central role that this
cytokine plays in promoting the production of C-reactive protein
(CRP), an important risk factor for myocardial infarction (10–
12). For example, high concentrations of CRP predicted the risk
of future cardiovascular disease in apparently healthy men (12).
CRP and IL-6 have other important health consequences in
addition to their role in cardiovascular disease. Elevated levels
of CRP and IL-6 predicted the development of type 2 diabetes
in a 4-year follow-up period in healthy women after adjustments
for key risk factors; among women in the highest vs. lowest
quartiles, the relative risk for developing diabetes was 7.5 for
IL-6 and 15.7 for CRP (13). In another study, elevated serum
IL-6 levels predicted future disability in older adults, a finding
that may reflect the effects of the cytokine on muscle atrophy,
andor the pathophysiologic role played by the cytokine in
particular diseases (14). Proinflammatory cytokines, including
IL-6, may slow muscle repair after injury and accelerate muscle
wasting (15); indeed, IL-6 and CRP also play a pathogenic role
in a range of diseases associated with disability among the elderly
(osteoporosis, arthritis, and congestive heart failure, among
others) (14).
Production of IL-6 and other proinflammatory cytokines can
be directly stimulated by depression and other negative emotions
and stressful experiences (16–20). Indeed, both physical and
psychological stressors can provoke transient increases in proin-
flammatory cytokines (21, 22). Additionally, negative emotions
contribute to greater risk for infection, prolonged infection, and
delayed wound healing (1–5), all processes that can fuel sus-
tained proinflammatory cytokine production. Thus, stressors
can directly affect the cells of the immune system and modulate
the secretion of proinflammatory cytokines. Accordingly, we
argue that distress-related immune dysregulation may be one
central mechanism behind a large and diverse set of health risks
associated with caregiving and other chronic stressors. In this
study, we tested the hypothesis that caregivers would show a
steeper increase in IL-6 levels over time than noncaregiving
controls. Additionally, we assessed the question of whether the
cessation of caregiving would have beneficial consequences for
IL-6 levels.
Materials and Methods
Participants. The 225 participants (119 caregivers and 106 con-
trols) were part of a longitudinal project on caregiving, stress,
and health in older adults (1, 2). The spousal dementia caregivers
were recruited from local dementia evaluation centers in area
hospitals, neurologists’ referrals, Columbus Alzheimer’s Disease
Association support groups and monthly newsletter, and respite
care programs. On entry into the study, caregivers were spending
a mean  SD of 9.72  7.70 h per day in caregiving-related
activities and reported they had been providing care for 4.91 
3.63 years.
Control participants were recruited through a variety of
sources including newspaper advertisements, notices posted in
senior citizen centers, and referrals from other participants;
potential control participants who reported any caregiving ac-
tivities were excluded. During recruitment we excluded caregiv-
ers or controls with immunologically related health problems
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such as cancer or recent surgeries and those taking any medi-
cations with broad immunological consequences.
For this study we analyzed frozen plasma samples from 6
consecutive years for all individuals in the cohort who were at
least 55 years old (only seven fell below this threshold) and had
provided at least two blood samples across the 6 years; 60% of
the sample had eight or more blood samples, reflecting the fact
that most participants had provided two samples from two
different time points within each year. As expected, a number of
the caregivers’ spouses died during the course of the longitudinal
study; by continuing to follow the caregivers, we were provided
with valuable data on caregiver functioning after caregiving
activities had ended (23). We also regularly added new caregivers
and controls to the cohort across the longitudinal data collection.
As described below, the statistical methods used allowed par-
ticipants to be measured at different intervals and different
numbers of times.
The 65 men and 160 women in this sample ranged in age from
55 to 89 on entry into this portion of the study (mean  70.58,
SD  8.03). The caregiver and control cohorts did not differ in
the proportion of women, 2(1)  1.14, P  0.29; age, F(1,123) 
1.64, P  0.20; ethnicity, 2(1)  1.36, P  0.24; or education,
2(4)  5.81, P  0.21. The mean education in both groups was
partial college, and we used education as a proxy for socioeco-
nomic status because many of our caregivers were older women
who had not worked outside the home. The comparability of
caregivers and controls had been closely monitored during
recruitment to assure that the cohorts were indistinguishable on
these key dimensions. When they entered this phase of data
collection, the 225 participants included 91 spouses who were
currently providing care for a spouse, 28 former caregivers whose
spouse had died by this point in the longitudinal study (mean
time since death  33.71 months, SD  19.00), and 106 controls
(68 married, 17 widowed, 17 separated or divorced, 4 never
married). Although the groups did differ in marital status at
entry, 2(3)  26.35, P  0.001, the inclusion of fewer intact
marriages among the controls worked against confirmation of
the experimental hypothesis: intact marriages are associated
with lower rates of morbidity and mortality and better immune
function (24). The Ohio State University Biomedical Research
Review Committee approved the project; all participants gave
written informed consent before participation.
Assessment of Stress, Depressive Symptoms, Loneliness, and Health-
Related Behaviors. The 10-item Perceived Stress Scale, adminis-
tered each time blood was drawn, assessed the degree to which
subjects perceived their daily life during the prior week as
unpredictable, uncontrollable, and overloading (25). Subjects
rated each item from 0 (never) to 4 (very often).
The Beck Depression Inventory (BDI) provided information
on the severity of depressive symptoms (26). The 13 items on the
short BDI cover affective, cognitive, and vegetative symptoms.
Participants’ self-reported loneliness was measured by using a
shortened version of the New York University Loneliness Scale
(27). The three-item version used in this study assessed how
often participants felt lonely, how lonely they felt, and how lonely
they thought they were compared with other people their own
age. Scores ranged from 3 to 18, with higher scores indicating a
greater sense of loneliness.
We collected health-related data to assess the possibility that
relationships between caregiving and IL-6 levels might simply
reflect the contribution of other variables. Plasma albumin levels
and body mass data provided information on nutritional status.
Health questions from the Older Adults Resources Survey (28)
assessed other underlying diseases. Several studies have found
excellent agreement between self-reports and hospital or phy-
sician records for specific conditions of interest to us, including
myocardial infarction, stroke, and diabetes (29, 30). Assessment
of health-related behaviors included recent medication use,
hours of sleep in the last 3 days, and recent alcohol intake (31).
Two questions assessed exercise (32).
Plasma IL-6 Levels. All blood samples were drawn between 8 and
11 a.m. to control for diurnal variation. Plasma samples frozen
at 40°C from caregivers and controls were thawed. IL-6 levels
were assayed by using a Quantikine High Sensitivity Immuno-
assay kit (R & D Systems) per kit instructions. Samples were run
neat in duplicate, and all samples for an individual were run in
the same assay.
Statistical Analyses. Analyses used the yearly means of the twice-
yearly IL-6 blood samples for increased stability; the average
correlation between pairs of blood samples within a year was r 
0.81 (range  0.72 to 0.89, P  0.001). IL-6 data were log-
transformed (base 10) to normalize the distributions before
analyses (14). All subsequent references to IL-6 refer to the
log-transformed variable.
Given these repeated measures on IL-6 for each individual,
the primary objective of the statistical analyses was to assess
individual and group differences in the pattern of change in IL-6
and determine whether any such differences were related to
other relevant variables. Multilevel models (33) were used to
address these questions. In such models, the outcome variable,
here IL-6, is expressed as a function of time, represented by age
in this study. In our models, IL-6 was represented as a linear
function of age, with each individual having a unique intercept
and slope. Age was scaled so that the intercept represented the
predicted level of IL-6 at age 55, and slope represented the
predicted change in IL-6 per year of aging. Intercepts and slopes
can be specified as either random, meaning they vary across
individuals, or fixed, meaning they are the same for all individ-
uals. Analysis using a fully random model yields estimates of the
mean and variance of intercepts and slopes and their covariance.
In the present context, such information was obtained simulta-
neously for each group: caregivers and controls. These models
can be extended by introducing additional variables (e.g., health
behaviors) that serve as predictors of intercepts and slopes; this
approach provides a mechanism for determining whether indi-
vidual or group differences in slope might be accounted for by
particular variables of interest.
Results of fitting a given model also include a deviance statistic
that allows for testing differences between models when one
model is a special case of another. For example, it is possible to
test the difference between a model specifying that controls and
caregivers have the same mean slope vs. a model, allowing those
means to be different. Results of this particular test will be of
primary interest in the present study. For such tests, the differ-
ence between the deviance statistics for two models provides a
2 statistic, with degrees of freedom equal to the difference in the
number of parameters estimated in the two models being
compared. Multilevel analyses were conducted by using LISREL
8.53 software.
To assess the possibility that relationships between caregiver
status and IL-6 might simply reflect the contribution of health
problems, medications, or health habits, two different kinds of
analyses were conducted. Group differences were assessed cross-
sectionally each year on a series of relevant variables. In addition,
a series of multilevel models investigated the possibility that
group differences in rate of change in IL-6 were a function of
health problems or health habits.
Results
Change in IL-6. We modeled change in IL-6 levels with a two-
group linear multilevel model, with measurement occasion as the
level-1 unit, participant as the level-2 unit, and age as the
predictor of IL-6. Age was centered at 55 (the youngest age used








in the sample) so that intercepts could be interpreted as pre-
dicted levels of IL-6 at that age. A model with both intercepts and
slopes specified as random parameters demonstrated a signifi-
cant linear trend over age for caregivers, mean slope ( SEM) 
0.018(0.004), P  0.001, but not for controls, mean slope 
0.005(0.004), P  0.157, and no significant parameter variances
or covariances. Intercepts showed significant interindividual
variability in the control group, variance  0.197(0.070), P 
0.005, but not in the caregiver group, variance  0.108(0.065),
P  0.093.
Because slopes did not vary significantly in the initial model,
slope was respecified as a fixed parameter. Intercept was allowed
to vary freely because its nonsignificant variance in the caregiver
group was largely caused by the selection of 55 as the intercept
age. The resulting model showed no significant decrement in fit
as compared with the model with random slopes, 2(4)  2.255,
not significant. The predicted rate of change in IL-6 for care-
givers, slope  0.017, was approximately four times as large as
that for controls, slope  0.004. A test of the equality of slopes
between caregivers and controls compared the fit of a model
with the slope parameters constrained to equality across groups
vs. a model without such a constraint. Slopes were significantly
different between groups, 2(1)  5.408, P  0.02. The fitted
functions for both caregivers and controls representing IL-6 as
a linear function of age are presented in Fig. 1.
As noted earlier, 28 of the caregivers’ spouses had already died
at the beginning of this portion of the longitudinal study, and an
additional 50 of the 119 spouses died during the 6 years of this
study. Additional analyses addressed the question of whether
caregivers’ steeper IL-6 slopes compared with controls might be
related to loss of the spouse. For example, it was possible that
cessation of caregiving substantially reduced the IL-6 slope,
reflecting the end of caregiving-related stressors. To investigate
these possibilities, we defined and compared mutually exclusive
groups of former and current caregivers. Former caregivers were
defined as those participants with at least three annual valid IL-6
measurements after the loss of a spouse; current caregivers
included all other caregivers. This approach produced groups of
40 former caregivers and 68 current caregivers. Importantly, for
the purposes of these analyses, only measurements taken before
the spouse’s death were retained for current caregivers, and only
measurements taken after the spouse’s death were retained for
former caregivers. These time periods were chosen because of
our interest in assessing the longer-term sequelae of caregiving
beyond what would be expected for normal bereavement-related
distress (35, 36).
IL-6 data from these groups were analyzed in a two-group
multilevel model with random intercepts and slopes. The mean
intercept for former caregivers, 0.023(0.112), P  0.839, and the
mean intercept for current caregivers, 0.165(0.098), P  0.091,
did not differ significantly, 2(1)  0.912, P  0.34. The mean
slope for former caregivers, 0.021(0.009), P  0.015, and the
mean slope for current caregivers, 0.015(0.006), P  0.014, also
did not differ significantly, 2(1)  0.321, P  0.571. A model
with fixed slopes showed a similar pattern of effects. Thus, there
were not statistically significant differences between former and
current caregivers in either absolute levels or change in IL-6 over
the course of this study.
Demographic Data. In accord with other researchers, we found
that men had higher levels of IL-6 than women, significantly so
for 3 of the 6 years of data collection. However, when controlling
for age [males were significantly older than females at entry into
the study, F(1,123)  30.88, P  0.0001], a significant difference
was found for only 2 years.
Ethnicity was categorized as African American or non-African
American, related to the small number of other minority par-
ticipants. IL-6 was consistently higher for African American than
for non-African American participants, significantly so for 4 of
the 6 years of data collection. The means  SD for African
Americans vs. non-African Americans, respectively, were
0.46(0.555) vs. 0.380(0.370), t(151)  0.630, P  0.530 for year
1; 0.588(0.467) vs. 0.408(0.381), t(176)  2.055, P  0.04 for
year 2; 0.680(0.489) vs. 0.448(0.419), t(156)  2.36, P  0.020
for year 3; 0.620(0.469) vs. 0.380(0.345), t(158)  2.86, P 
0.005 for year 4; 0.588(0.414) vs. 0.447(0.416), t(156)  1.36,
P  0.177 for year 5; and 0.700(0.441) vs. 0.438(0.372), t(124) 
2.43, P  0.016 for year 6.
To assess longitudinal effects related to ethnicity, we specified
race as a predictor of IL-6 intercept and slope. Ethnicity
predicted individual differences in intercept, 0.406(0.147), P 
0.006, such that non-African Americans had a lower mean
intercept (at age 55) than did African Americans. However,
ethnicity did not predict slope, 0.011(0.008), P  0.176.
Further multilevel models included gender and ethnicity when
caregiver status was used to predict slope. Neither gender nor
ethnicity was significantly associated with slope, whereas care-
giver status remained a significant predictor when these demo-
graphic variables were included in the model.
Stress, Depressive Symptoms, and Loneliness. Caregivers reported
greater stress than controls across each of the 6 yearly aggregated
Perceived Stress Scale assessments, with group differences that
were P  0.05 or larger for all but year 6 (Fig. 2 Upper). Further
analyses comparing stress in current and former caregivers did
not show significant differences in any of the 6 years, all P  0.18.
Caregivers reported significantly greater loneliness than con-
trols in each of the 6 years of data collection (Fig. 2 Lower).
Subsequent analyses comparing loneliness in current and former
caregivers did not show significant differences in any of the 6
years; indeed, with the exception of year 1, t(79)  1.52, P 
0.80, the differences between current and former caregivers were
very small, t  1, for all other years.
Further analyses addressed the question of whether the ob-
served group difference in change in IL-6 might be reflecting
group differences in severity of stress or depressive symptoms or
loneliness rather than caregiver status per se. None of these
variables alone significantly predicted IL-6 slope. When care-
giver status and any of these variables were used to predict slope,
caregiver status again predicted slope, whereas the other vari-
Fig. 1. Modeled change in IL-6 in caregivers vs. noncaregivers. The slope for
caregivers, mean  0.017(0.004), P  0.001, was significant, whereas that for
controls, mean  0.004(0.003), P  0.212, was not. Ninety-five percent confi-
dence intervals for slopes were {0.009, 0.025} for caregivers and {0.002,
0.010} for controls. The two slopes were significantly different from one
another, 2(1)  6.66, P  0.01, and caregivers’ average rate of increase was
about four times greater than that of noncaregivers.
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ables did not. Thus, the evidence suggested that the caregiver-
related differences in IL-6 slope were not simply a function of
differences in stress, depressive symptoms, or loneliness between
caregivers and noncaregivers.
Health-Related Data. Further analyses assessed the possibility that
the relationships between caregiver status and IL-6 might simply
reflect the contribution of health habits associated with higher
IL-6 andor chronic health problems. Analyses yielded no
significant group differences within any of the 6 years in the
proportion of participants in each group who reported specific
chronic health conditions that have been associated with higher
IL-6, including stroke, diabetes, and cancer (14). It should be
noted that base rates for each were low related to our exclusion
criteria at study entry. A significantly higher proportion of
caregivers (22.5%) than controls (7.7%) answered yes to the
Older Adults Resources Survey question about heart trouble in
year 1, 2(1)  6.72, P  0.01, but the proportions were not
different in any subsequent years, P  0.34. Similarly, a signif-
icantly higher proportion of caregivers (49.5%) than controls
(33.8%) answered yes to the Older Adults Resources Survey
question about hypertension in year 5, 2(1)  4.21, P  0.04, and
a marginally higher proportion did so in year 6, 2(1)  3.49, P 
0.06, but not in any other years, P  0.21.
Most older adults take some medication; of greatest concern
were those medications that have been associated with alter-
ations in IL-6, particularly the statins and estrogen. Analyses
showed no differences in the proportion of caregivers and
controls reporting use of statins, P  0.41, or the proportion of
women on estrogen, P  0.34. There were no significant differ-
ences between groups in the proportion reporting regular use of
aspirin or other over-the-counter analgesics, P  0.19, beta
blockers, calcium channel blockers, or diuretics, all P  0.29.
Participants were considered smokers if they reported smok-
ing during any year they were in the study. Although caregiver
status was marginally related to smoking status, 2(1)  3.54, P 
0.06, this relationship reflected the fact that fewer caregivers
smoked than controls (3% vs. 9%, respectively). Group differ-
ences were assessed each year in body mass index (BMI),
exercise, number of chronic health problems, serum albumin,
and white blood cell count; there were no significant group
differences for any year on any of these variables. In the case of
alcohol intake, caregivers reported 2.49  4.37 drinks during the
week before assessment in year 4, compared with 1.31  2.41 in
controls, t  2.17, P  0.03; whereas caregivers had consistently
higher values across the 6 years of data, differences in the other
5 years were not significant, P  0.10, and mean weekly
consumption in both groups was similarly low, i.e., fewer than
three drinks per week at all time points for both groups.
Other researchers have shown that higher levels of IL-6 levels
are associated with greater body fat and a higher BMI (34). In
our data, BMI is associated with IL-6 in terms of the intercept,
0.023(0.005), P  0.001; that is, heavier individuals do have
higher levels of IL-6. However, this effect does not change when
caregiver status is included as a predictor in the model; i.e., the
conditional effect of BMI on intercept  0.023(0.005), P  0.001.
Moreover, BMI is not related to the differences in slope between
caregivers and controls; thus, the effect of BMI (alone) on
slope  0.000(0.001), P  0.418, and the effect of caregiver
status (with BMI) on slope  0.014(0.005), P  0.004, whereas
the effect of BMI (with caregiver status) on slope 
0.001(0.001), P  0.294.
Sleep disturbances are associated with alterations in IL-6 (37),
and sleep differences between caregivers and controls have
frequently been reported (8). Caregivers reported less sleep over
the preceding 3 nights at each measurement occasion than
controls, with differences in the first 2 years of this study,
t(118)  2.33, P  0.02, and t(128)  1.98, P  0.05, without
significant differences in the latter 4 years, P  0.40. However,
both the effect of sleep (alone) on the intercept, 0.000(0.013),
P  0.981, and the effect of sleep (with caregiver status) on the
intercept, 0.001(0.013), P  0.963, were not significant. Similarly,
sleep loss (alone) did significantly affect the slope, 0.002(0.001),
P  0.196, whereas caregiver status (with sleep loss) had a
significant effect on slope, 0.013(0.005), P  0.009, and sleep loss
(with caregiver status) did not have a significant effect on
slope  0.002(0.001), P  0.153.
A further series of multilevel models investigated the possi-
bility that the group difference in rate of change in IL-6 could
be accounted for by group differences in any of the health
problems or health habits described above. These analyses are
pivotal, because they are much more powerful than cross-
sectional analyses or strategies such as ANOVA in that they
analyze six repeated measures, use a specific model for the
pattern of change, and allow for individual and group differences
in the parameters of the model. Only two variables were
significant predictors of slope by themselves: participants who
reported greater alcohol consumption had a steeper increase in
IL-6 slope, 0.002(0.001), P  0.009, and more intensive exercise
was associated with slower age-related increases in the IL-6
Fig. 2. Group differences in perceived stress scores (Upper) and loneliness
[New York University Loneliness Scale (NYUL); Lower] by year. Caregivers
consistently reported more stress, with group differences that were P  0.05
or larger for all but year 6, with 1–6, respectively: t(157)  4.70, P  0.001;
t(178)  3.69, P  0.001; t(165)  1.98, P  0.05; t(169)  2.56, P  0.01; t(168) 
2.01, P  0.046; and t(143)  0.97, P  0.33. Similarly, caregivers consistently
reported higher loneliness, with significant differences across all 6 years of the
study, with 1–6 respectively: t(137)  5.50, P  0.001; t(167)  4.84, P  0.001;
t(153)  4.58, P  0.001; t(169)  3.02, P  0.003; t(161)  4.04, P  0.001; and
t(135)  4.34, P  0.001.








slope, 0.002(0.001), P  0.001. Most importantly, caregiver
status was always a significant predictor of slope, even when
these or other key health behaviors were included in the model.
Thus, despite the fact that the number of analyses we conducted
to evaluate other health-related variables substantially inflated
the possibility of finding significance where null findings were
desirable, we found no evidence that the differences in IL-6
patterns between caregivers and controls were simply a function
of chronic health problems, medications, or health habits.
Comment
IL-6 is associated with a variety of age-related illnesses (10,
13–15, 38). Accordingly, the finding that caregivers’ average rate
of increase in IL-6 was about four times as large as that of control
participants has notable implications for morbidity and mortal-
ity. Indeed, these data provide important evidence of a key
mechanism through which chronic stressors may have potent
health consequences for older adults, accelerating risk of a host
of age-related diseases.
What might be the consequences of these differences over
time? Epidemiological studies of individuals 65 or older have
found that the highest quartile had values 3.19 pgml (39, 40).
As one illustration of risk, participants in the upper quartile had
a 2-fold greater risk of death compared with the lowest quartile
(39). Applying this value to the data from our model suggests
that caregivers would on average cross that line around age 75,
whereas controls would cross sometime after age 90.
The mean rate of increase in IL-6 among former caregivers did
not differ from that of current caregivers even several years after
the death of the impaired spouse. The absence of any notable
improvement after cessation of caregiving may be related to both
biological and psychological mechanisms. Stress and depression
can permanently alter the responsiveness of the immune system
(41–44). For example, prior stressor exposure appears to prime
proinflammatory cytokine responses, such that subsequent ex-
posure to a bacterial endotoxin, lipopolysaccharide, resulted in
a larger or more rapid induction of proinflammatory cytokines
in stressed rats compared with nonstressed controls (41).
The evidence that prior stress produces exaggerated proin-
flammatory cytokine responses to infection (41) is important in
light of data discussed earlier: caregivers report more infectious
illness episodes, and they have poorer immune responses to
influenza virus and pneumococcal pneumonia vaccines than
noncaregivers (1–4). Thus, stressed caregivers are likely to be at
greater risk for infection, and their inflammatory responses to
these challenges could be exaggerated and prolonged through
this mechanism as well.
Although there are biological mechanisms that may lead to
persistent IL-6 changes even after the cessation of caregiving, it
is also important to highlight psychological processes that may
also have physical repercussions. In other longitudinal data
collected from our participants before and after the death of the
impaired spouse, we examined changes in the same individuals
over the period they were caregiving and then after the death of
their spouse; we found that former caregivers’ scores on mea-
sures of depression and loneliness did not ‘‘rebound’’ to levels
comparable to noncaregivers and, in fact, remained similar to
those of current caregivers up to 3 years after caregiving had
ceased (23). These findings stand in contrast to evidence from
longitudinal studies of spousal bereavement in the general
(noncaregiver) population that have shown that depression
returns to baseline within 1–2 years postloss (35, 36); thus, the
changes in caregivers are not simply an artifact of bereavement.
Other longitudinal studies have found that caregivers show some
improvement in psychological functioning after bereavement,
albeit without returning to normative levels (7, 45, 46). Indeed,
the loss of social supports and consequent increased loneliness
are well documented correlates of dementia caregiving (47);
after providing care for 3–10 years, many former caregivers may
not emerge from the experience with the same social support
system that they had before the spouse’s dementia. Social
isolation has clear ties to morbidity and mortality (24), and thus
may serve as an additional conduit for perpetuation of caregiv-
ing-related stresses.
In one large population-based study of the elderly drawn from
a random, stratified sample, caregivers reported less stress
during caregiving on average than we and others have found
(48). Although there are key differences between the two
cohorts in the way caregivers were defined as such, it is note-
worthy that all-cause mortality among their randomly selected
caregivers who described themselves as strained was 63% greater
than that of noncaregiving controls (9). Our IL-6 findings
provide one viable mechanism that could explain caregivers’
substantial differences in mortality across a range of illnesses.
More broadly, our data have implications well beyond care-
giving; they suggest that if other chronic stressors similarly
provoke persistent distress in older adults, then they may also
accelerate age-related increases in IL-6. Indeed, we found
preliminary evidence of ethnicity differences, with African
Americans having higher IL-6 than non-African Americans.
Such changes may be one factor in the well documented racial
and ethnic disparities in health (49) and deserve further
investigation.
Other researchers have demonstrated that higher plasma IL-6
levels are associated with adverse health habits: values are higher
in smokers than nonsmokers, in individuals who report
less physical activity, in those whose sleep is impaired, and in
those with a higher BMI, all behaviors that are adversely affected
by stress (14, 34, 37, 50–52). Although the linkage between
caregiving and IL-6 was still significant in our data after ac-
counting for these health behaviors, chronic stressors are also
likely to affect IL-6 and thus health through these pathways as
well.
IL-6 is associated with a spectrum of age-associated diseases
whose onset and course may be influenced by proinflammatory
cytokines. The finding that caregivers’ average rate of increase
in IL-6 was about four times as large as that of noncaregivers
suggests that a chronic stressor is capable of substantially
augmenting normal age-related increases, effectively prema-
turely aging the immune response. These data provide important
evidence of a key mechanism through which chronic stressors
may have potent health consequences for older adults, acceler-
ating risk of a host of age-related diseases.
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